Sort
10,766 grants matching “checkpoint inhibitor”
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
$598,885Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA
The NOTCH Signaling Pathway in Large Vessel Vasculitis
$598,823Cornelia M Weyand · Mayo Clinic Rochester · R01 · FY2023 · HL
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$598,289Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2020 · NS
Development Therapeutics Branch Clinical Trials
$598,166Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Genotypes and Phenotypes of Apoptosis and Risk of Head and Neck Cancer
$597,734Qingyi Wei · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Leveraging DNA damage repair pathways as therapeutic targets in womens cancers
$597,694Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity
$597,582Iris Z Jaffe · Tufts Medical Center · R01 · FY2023 · CA
Overcoming metastatic spread of osteosarcoma with RNA loaded nanoparticles
$597,571Elias Sayour · University Of Florida · R01 · FY2024 · CA
Radiogenomic Credentialing of Head and Neck Cancer Models
$597,483Mukund Seshadri · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
RIG-I Activating Nanoparticles for Immunopotentiation
$597,471John Tanner Wilson · Vanderbilt University · R01 · FY2025 · EB
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$597,298Farrokh Dehdashti · Washington University · R01 · FY2021 · CA
Targeting B7-H3 in ovarian cancer
$597,170Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Microtubule Regulation
$597,169Don W. Cleveland · Ludwig Institute For Cancer Res Ltd · R01 · FY2008 · GM
Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)
$597,082Noah M Hahn · Johns Hopkins University · R01 · FY2023 · CA
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$596,948Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
$596,869T.-C. Wu · Johns Hopkins University · R01 · FY2019 · CA
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
$596,833Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Optimizing prognostic and predictive algorithms using residual disease (RD) genomic biomarkers in HER2+ and TNBC
$596,748Lisa A Carey · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Radiation-induced translational control of gene expression
$596,528Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
The Role of the Tumor Suppressor ARID1A in R loop Homeostasis and Tumor Immunity
$596,336Diana Clare Hargreaves · Salk Institute For Biological Studies · R01 · FY2024 · CA
Preclinical and Clinical Models of Drug Induced Kidney Injury
$596,308Melanie S Joy · University Of Colorado Denver · R01 · FY2024 · CA
Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays
$596,244Stephen R. Bowen · University Of Washington · R01 · FY2023 · CA
Mechanism of estrogen independent proliferation in ER+ breast cancer cells
$596,232Andrea Hope Bild · Beckman Research Institute/City Of Hope · U01 · FY2021 · CA
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer
$596,098Andrew Y Koh · Ut Southwestern Medical Center · R01 · FY2021 · CA
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer
$596,098Andrew Y Koh · Ut Southwestern Medical Center · R01 · FY2020 · CA